ANALYSES OF PUBLIC POLICIES--COVERAGE OF HIV DRUGS

公共政策分析——艾滋病毒药物的覆盖范围

• 批准号: 2777256
• 负责人: ROBERT J BUCHANAN
• 金额: $ 4万
• 依托单位: MEDICAL UNIVERSITY OF SOUTH CAROLINA
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-09-01 至 1999-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2777256
• 关键词: AIDS therapy; HIV infections; Medicare /Medicaid; clinical research; health care cost /financing; health insurance; health services research tag; health surveys; human data; managed care; opportunistic infections; population survey; public assistance; public health; quality of life

Drug therapies for the treatment of HIV and related opportunistic infections have emerged as the major method to improve the quality of life and increase the length of survival for people with HIV disease. The objectives of this research are to describe and analyze public programs and policies affecting the third-party coverage of medications needed by people with HIV. The study will focus on: HIV/AIDS drug assistance programs and HIV consortia funded by Title II of the Ryan White CARE Act; the programs funded by Title I of the Ryan White CARE Act in eligible metropolitan areas; prescription drug policies implemented by the state Medicaid programs, with a focus on managed care; and state regulation of the coverage of HIV-related medications by private health insurers and managed care plans. This project will identify any policies implemented by the state Medicaid programs (including managed care policy guidelines), the programs funded by Title I and Title II of the CARE Act, and the state regulation of private health coverage that increase the access that people with HIV have to appropriate drug therapies. Working with Lowcountry AIDS Services, a non-profit AIDS service organization in South Carolina, the study will identify innovate policies that can be used as models to assist other states develop public policies to increase the access that people with HIV have to needed drug therapies.

治疗艾滋病毒和相关机会性感染的药物疗法 感染已成为改善生活质量的主要方法 并延长艾滋病患者的存活时间。的 本研究的目的是描述和分析公共项目 影响第三方所需药物覆盖的政策， 艾滋病毒感染者。该研究将重点关注：艾滋病毒/艾滋病药物援助 由瑞安白色关怀法案第二章资助的计划和艾滋病毒联盟; 由瑞安白色关怀法案第一章资助的项目， 大都市地区;国家实施的处方药政策 医疗补助计划，重点是管理式护理;以及 私营医疗保险公司对艾滋病毒相关药物的承保范围， 管理式护理计划该项目将确定由以下方面执行的任何政策： 州医疗补助计划（包括管理式护理政策指南）， 由《关怀法案》第一章和第二章资助的项目，以及国家 监管私人医疗保险，增加人们获得医疗保险的机会 艾滋病病毒感染者必须接受适当的药物治疗。与低地艾滋病合作 服务，一个非营利性的艾滋病服务组织在南卡罗来纳州， 一项研究将确定创新政策，可作为模式， 其他国家则制定公共政策， 艾滋病病毒携带者需要药物治疗。